FDA OKs First Trial of Stem Cells to Heal Spine Injuries
The Food and Drug Administration cleared the way on Friday for California biotech firm Geron to begin human clinical trials of its experimental embryonic stem cell-based therapy to heal spinal cord injuries in paraplegic patients. Geron claims this is the first such trial in humans.